June 27, 2012 8:25 AM | 1 min read
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
Cantor Fitzgerald initiates its coverage on Accelrys (NASDAQ: ACCL) with a Buy rating and a price target of $10 per share. Cantor Fitzgerald notes, "Accelrys is a pure-play, scientific software products and services company that provides tools across the R&D life cycle for the pharmaceutical, academic, food and beverage, chemical and materials industries. Since the merger with comparably-sized software provider Symyx in mid-2010, ACCL has focused on integration, restructuring, and strengthening its product portfolio over the last 18+ months. Although both ACCL and Symyx as standalone companies have struggled with top-line growth over several years, we believe the combined company has emerged better positioned to capitalize on high-growth opportunities within the scientific informatics market."ACCL closed at $8.03 on Tuesday.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.